Publications

Liu J, Gong T, Xu X, Fox KM, Oates M, Gandra SR. Heavy clinical and economic burden of osteoporotic fracture among elderly female Medicare beneficiaries. Osteoporos Int. 2022 Feb;33(2):413-423. doi: 10.1007/s00198-021-06084-1.

Liu J, Laster A, Xu X, Guo H, Oates M, Gandra SR. Patterns of teriparatide and sequential antiresorptive agent treatment among elderly female Medicare beneficiaries. J Bone Miner Res. 2021 Dec;36(12):2309-2316. doi: 10.1002/jbmr.4439. 

Liu J, Guo H, Rai P, Pinto L, Barron R. Medication persistence and risk of fracture among female Medicare beneficiaries diagnosed with osteoporosis. Osteoporos Int. 2018 Nov;29(11):2409-2417. doi: 10.1007/s00198-018-4630-6.

Eidman KE, Wetmore JB. Managing hyperparathyroidism in hemodialysis: Role of etelcalcetide. Int J Nephrol Renovasc Dis. 2018 Feb 5;11:69-80. doi: 10.2147/IJNRD.S128252.

Wetmore JB, Weinhandl ED, Zhou J, Gilbertson DT. Relative incidence of acute adverse events with ferumoxytol compared to other intravenous iron compounds: A matched cohort study. PLoS One. 2017 Jan 30;12(1):e0171098. doi: 10.1371/journal.pone.0171098.

Yusuf AA, Matlon TJ, Grauer A, Barron R, Chandler D, Peng Y. Utilization of osteoporosis medication after a fragility fracture among elderly Medicare beneficiaries. Arch Osteoporos. 2016 Dec;11(1):31. doi: 10.1007/s11657-016-0285-0.

Wetmore JB, Liu J, Dluzniewski PJ, Ishani A, Block GA, Collins AJ. Geographic variation of parathyroidectomy in patients receiving hemodialysis: A retrospective cohort analysis. BMC Surg. 2016 Nov 29;16(1):77. doi: 10.1186/s12893-016-0193-7.

Block GA, Yusuf AA, Danese MD, Wirtz H, Hu Y, Do TP, Cooper K, Gilbertson DT, Bradbury BD, Collins AJ. Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysis. BMC Nephrol. 2016 Nov 4;17(1):166. doi: 10.1186/s12882-016-0382-8.

Wetmore JB, Liu J, Wirtz HS, Gilbertson DT, Cooper K, Nieman KM, Collins AJ, Bradbury DB. Geovariation in fracture risk among patients receiving hemodialysis. Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1413-21. doi: 10.2215/CJN.11651115.

Wetmore JB. Parathyroidectomy: Complex decisions about a complex procedure. Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1133-5. doi: 10.2215/CJN.04950516.

Wetmore JB, Liu J, Do TP, Low KA, Ishani A, Bradbury BD, Block GA, Collins AJ. Changes in secondary hyperparathyroidism-related biochemical parameters and medication use following parathyroidectomy. Nephrol Dial Transplant. 2016 Jan;31(1):103-11. doi: 10.1093/ndt/gfv291.

Yusuf AA, Hu Y, Singh B, Menoyo JA, Wetmore JB. Serum potassium levels and mortality in hemodialysis patients: A retrospective cohort study. Am J Nephrol. 2016;44(3):179-86. doi: 10.1159/000448341.

St. Peter WL, Yusuf AA, Do T, Lowe KA, Liu J, Nieman KM, Bradbury BD, Collins AJ. Parathyroid hormone change after cinacalcet initiation and one-year clinical outcome risk: A retrospective cohort study. BMC Nephrol. 2015 Mar 31;16:41. doi: 10.1186/s12882-015-0030-8.

Ishani A, Liu J, Wetmore JB, Lowe K, Do T, Bradbury BD, Block GA, Collins AJ. Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis. Clin J Am Soc Nephrol. 2015 Jan 7;10(1):90-7. doi: 10.2215/CJN.03520414.

Arneson TJ, Li S, Liu J, Kilpatrick RD, Newsome BB, St. Peter WL. Trends in hip fracture rates in US hemodialysis patients, 1993-2010. Am J Kidney Dis. 2013 Oct;62(4):747-54. doi: 10.1053/j.ajkd.2013.02.368.

Kilpatrick RD, Newsome BB, Zaun D, Liu J, Solid CA, Nieman K, St. Peter WL. Evaluating real-world use of cinacalcet and biochemical response to therapy in US hemodialysis patients. Am J Nephrol. 2013;37(4):389-98. doi: 10.1159/000350213.

Newsome BB, Kilpatrick RD, Liu J, Zaun D, Solid CA, Nieman K, St. Peter WL. Racial differences in clinical use of cinacalcet in a large population of hemodialysis patients. Am J Nephrol. 2013;38(2):104-14. doi: 10.1159/000353298

Li S, Chen YW, Peng Y, Foley RN, St. Peter WL. Trends in parathyroidectomy rates in US hemodialysis patients from 1992 to 2007. Am J Kidney Dis. 2011 Apr;57(4):602-11. doi: 10.1053/j.ajkd.2010.10.041. 

Block GA, Zaun D, Smits G, Persky M, Brillhart S, Nieman K, Liu J, St. Peter WL. Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients. Kidney Int. 2010 Sep;78(6):578-89. doi: 10.1038/ki.2010.167.

St. Peter WL, Fan Q, Weinhandl ED, Liu J. Economic evaluation of sevelamer versus calcium-based phosphate binders in hemodialysis patients: A secondary analysis using Centers for Medicare & Medicaid Services data. Clin J Am Soc Nephrol. 2009 Dec;4(12):1954-61. doi: 10.2215/CJN.04100609.

St. Peter WL, Li S, Liu J, Gilbertson DT, Arneson TJ, Collins AJ. Effects of monthly dose and regular dosing of intravenous active vitamin D use on mortality among patients undergoing hemodialysis. Pharmacotherapy. 2009 Feb;29(2):154-64. doi: 10.1592/phco.29.2.154.

St. Peter WL, Li Q, Liu J, Persky M, Nieman K, Arko C, Block GA. Cinacalcet use patterns and effect on laboratory values and other medications in a large dialysis organization, 2004 through 2006. Clin J Am Soc Nephrol. 2009 Feb;4(2):354-60. doi: 10.2215/CJN.05241008. 

Posters & Presentations

Treatment Patterns and Persistency Following the First Biologic DMARD in Patients with Rheumatoid Arthritis: A Real-World Analysis of 2012-2016 US Medicare Data. Robin Dore, Lawrence Chang, Yuanyuan Ji, Suying Li, Jenya Antonova, Mark Genovese. Presented at: American College of Rheumatolgy /Association of Rheumatology Professionals (ACR/ARP) Annual Meeting, 2019  (Oral Presentation)

Who Prescribed Which Osteoporosis Medication to Whom. Jiannong Liu, Haifeng Guo, Tingting Gong, Yi Peng. Presented at: American College of Rheumatolgy /Association of Rheumatology Professionals (ACR/ARP) Annual Meeting, 2019.

Differences in Clinical Outcomes after Fracture Hospitalization in Elderly Men and Women. Jiannong Liu, Haifeng Guo, Yi Peng. Presented at American Society for Bone and Mineral Research (ASBMR) Annual Meeting, 2019.     

Methodological Considerations in Evaluating Treatment Differences in Fracture Outcomes among Female Medicare Beneficiaries Initiating Osteoporosis Medications. Jiannong Liu, Haifeng Guo, Rich Barron, Lionel Pinto. Presented at the American Society of Bone and Mineral Research Annual Meeting, 2017.

Characteristics of Patients at High One-Year Fracture Risk. Akeem A Yusuf, Yan Hu, David Chandler, Barry Crittenden, Rich Barron. Presented at the American Society of Bone and Mineral Research Annual Meeting, 2016.

Predictors of Imminent Fracture Risk in Medicare-Enrolled Men and Women. Akeem A Yusuf, Yan Hu, David Chandler, Barry Crittenden, Rich Barron. Presented at the American Society of Bone and Mineral Research Annual Meeting, 2016.

Fracture Risk after Discontinuation of Denosumab. Akeem Yusuf, Haifeng Guo, Akhila Balasubramanian, Nicola Pannacciulli, Rachel Wagman, J. Michael Sprafka. Presented at the American Society of Bone and Mineral Research Annual Meeting, 2016.

Utilization of Osteoporosis Medications after a Fragility Fracture among Elderly Medicare Beneficiaries. Akeem A. Yusuf, Tom Matlon, Andreas Grauer, Rich Barron, David Chandler, Yi Peng. Presented at the American Society of Bone and Mineral Research Annual Meeting, 2015.

Publications

Meyer M, Wetmore JB, Weinhandl ED, Roetker NS. Association of nondihydropyridine calcium channel blockers versus β-adrenergic receptor blockers with risk of heart failure hospitalization. Am J Cardiol. 2023 Jun 15;197:68-74. doi: 10.1016/j.amjcard.2023.04.013. 

Wetmore JB, Yan H, Peng Y, Gilbertson DT, Herzog CA. Development and outcomes of hyperkalemia in hospitalized patients: potential implications for care. Am Heart J. 2021 Nov;241:59-67. doi.org/10.1016/j.ahj.2021.07.006.

Charytan DM, Natwick T, Solid CA, Li S, Gong T, Herzog CA. Comparative effectiveness of medical therapy, percutaneous revascularization, and surgical coronary revascularization in cardiovascular risk subgroups of patients with CKD: A retrospective cohort study of Medicare beneficiaries. Am J Kidney Dis. 2019 Oct;74(4):463-473. doi: 10.1053/j.ajkd.2019.04.018.

Gibbons RJ. Imperfect data can still provide important answers. JACC: Cardiovasc Imaging. 2019 Aug;12(8 Pt 1):1427-1429. doi: 10.1016/j.jcmg.2018.04.017. 

Herzog CA, Natwick, T, Li S, Charytan DM. Comparative utilization and temporal trends in cardiac stress testing in US Medicare beneficiaries with and without chronic kidney disease. JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 1):1420-1426. doi: 10.1016/j.jcmg.2018.04.012.

Herzog CA. Congestive heart failure and chronic kidney disease: The cardiorenal/nephrocardiology connection. J Am Coll Cardiol. 2019 Jun 4;73(21):2701-2704. doi: 10.1016/j.jacc.2019.03.474.

Wetmore JB, Peng Y, Gilbertson DT, Liu J. Relation of race, apparent disability, and stroke risk with warfarin prescribing for atrial fibrillation in patients receiving maintenance hemodialysis. Am J Cardiol. 2019 Feb 15;123(4):598-604. doi: 10.1016/j.amjcard.2018.11.020. 

Wanner C, Herzog CA, Turakhia MP; Conference Steering Committee. Chronic kidney disease and arrhythmias: Highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2018 Aug;94(2):231-234. doi: 10.1016/j.kint.2018.05.005.

Turakhia MP, Blankestijn PJ, Carrero JJ, Clase CM, Deo R, Herzog CA, Kasner SE, Passman RS, Pecoits-Filho R, Reinecke H, Shroff GR, Zareba W, Cheung M, Wheeler DC, Winkelmayer WC, Wanner C; Conference Participants. Chronic kidney disease and arrhythmias: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Eur Heart J. 2018 Jun 21;39(24):2314-2325. doi: 10.1093/eurheartj/ehy060. 

O’Lone E, Viecelli AK, Craig JC, Tong A, Sautenet B, Roy D, Herrington WG, Herzog CA, Jafar T, Jardine M, Krane V, Levin A, Malyszko J, Rocco MV, Strippoli G, Tonelli M, Wang AYM, Wanner C, Zannad F, Winkelmayer WC, Webster AC, Wheeler DC. Cardiovascular outcomes reported in hemodialysis trials. J Am Coll Cardiol. 2018 Jun 19;71(24):2802-2810. doi: 10.1016/j.jacc.2018.04.012. 

Nadim MK, Forni LG, Bihorac A, Hobson C, Koyner JL, Shaw A, Amaoutakis GJ, Ding X, Engelman DT, Gasparovic H, Gasparovic V, Herzog CA, Kashani K, Katz N, Liu KD, Mehta RL, Ostermann M, Pannu N, Pickkers P, Price S, Ricci Z, Rich JB, Sajja LR, Weaver FA, Zarbock A, Ronco C, Kellum JA. Cardiac and vascular surgery-associated acute kidney injury: The 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) Group. J Am Heart Assoc. 2018 Jun 1;7(11):e008834. doi: 10.1161/JAHA.118.008834.  

Eckardt KU, Bansal N, Coresh J, Evans M, Grams ME, Herzog CA, James MT, Heerspink HJ, Pollock CA, Stevens PE, Kurella Tamura M, Tonelli MA, Wheeler DC, Winkelmayer WC, Cheung M, Hemmelgarn BR. Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2018 Jun;93(6):1281-1292. doi: 10.1016/j.kint.2018.02.006.

Weir MA, Herzog CA. Beta blockers in patients with end-stage renal disease-evidence-based recommendations. Semin Dial. 2018 May;31(3):219-225. doi: 10.1111/sdi.12691.

Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, Moe SM, Shroff R, Tonelli MA, Toussaint ND, Vervloet MG, Leonard MB. Diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update. Ann Intern Med. 2018 Mar 20;168(6):422-430. doi: 10.7326/M17-2640.  

Wetmore JB, Molony JT, Liu J, Peng Y, Herzog CA, Collins AJ, Gilbertson DT. Readmissions following a hospitalization for cardiovascular events in dialysis patients: A retrospective cohort study. J Am Heart Assoc. 2018 Feb 13;7(4):e007231. doi: 10.1161/JAHA.117.007231. 

Bansal VK, Herzog CA, Sarnak MJ, Choi MJ, Mehta R, Jaar BG, Rocco MV, Kramer H. Oral anticoagulants to prevent stroke in nonvalvular atrial fibrillation in patients with CKD stage 5D: An NKF-KDOQI Controversies Report. Am J Kidney Dis. 2017 Dec;70(6):859-868. doi: 10.1053/j.ajkd.2017.08.003.

Asinger RW, Shroff GR, Simegn MA, Herzog CA. Anticoagulation for nonvalvular atrial fibrillation: Influence of epidemiologic trends and clinical practice patterns on risk stratification and net clinical benefit. Circ Cardiovasc Qual Outcomes. 2017 Sep;10(9):e003669. doi: 10.1161/CIRCOUTCOMES.117.003669.

Shroff GR, Li S, Herzog CA. Trends in discharge claims for acute myocardial infarction among patients on dialysis. J Am Soc Nephrol. 2017 May;28(5):1379-1383. doi: 10.1681/ASN.2016050560.

Shroff GR, Solid CA, Bloomgarden Z, Halperin JL, Herzog CA. Temporal trends in ischemic stroke and anticoagulation therapy for non-valvular atrial fibrillation: Effect of diabetes. J Diabetes. 2017 Feb;9(2):115-122. doi: 10.1111/1753-0407.12392.

Shroff GR, Herzog CA. Coronary revascularization in patients with CKD stage 5D: Pragmatic considerations. J Am Soc Nephrol. 2016 Dec;27(12):3521-3529. doi: 10.1681/ASN.2016030345.

Herzog CA. Use of oral anticoagulation in the management of atrial fibrillation in patients with ESRD: Verdict 2. Clin J Am Soc Nephrol. 2016 Nov 7;11(11):2095-2096. doi: 10.2215/CJN.09470916. 

Shroff GR, Solid CA, Herzog CA. Impact of acute coronary syndromes on survival of dialysis patients following surgical or percutaneous coronary revascularization in the United States. Eur Heart J Acute Cardiovasc Care. 2016 Jun;5(3):205-13. doi: 10.1177/2048872615574106.  

Sandoval Y, Herzog CA, Love SA, Cao J, Hu Y, Wu AH, Gilbertson D, Brunelli SM, Young A, Ler R, Apple FS. Prognostic value of serial changes in high-sensitivity cardiac troponin I and T over 3 months using reference change values in hemodialysis patients. Clin Chem. 2016 Apr;62(4):631-8. doi: 10.1373/clinchem.2015.251835.

Bovitz T, Gilbertson DT, Herzog CA. Administrative data and the philosopher’s stone: Turning heart failure claims data into quantitative assessment of left ventricular ejection fraction. Am J Med. 2016 Feb;129(2):223-5. doi: 10.1016/j.amjmed.2015.10.003.

Shroff GR, Li S, Herzog CA. Trends in mortality following acute myocardial infarction among dialysis patients in the United States over 15 years. J Am Heart Assoc. 2015 Oct 12;4(10):e002460. doi: 10.1161/JAHA.115.002460.

Shroff GR, Herzog CA. β-blockers in dialysis patients: A nephrocardiology perspective. J Am Soc Nephrol. 2015 Apr;26(4):774-6. doi: 10.1681/ASN.2014080831.

Shroff GR, Solid CA, Herzog CA. Medicare claims for myocardial infarction as primary vs. secondary diagnosis. Int J Cardiol. 2015 Mar 1;182:412-3.  doi: 10.1016/j.ijcard.2014.12.141. 

Kalra A, Shroff GR, Herzog CA. Safety of ultrasound contrast agents in patients with intracardiac shunts. J Am Soc Echocardiogr. 2014 Dec;27(12):1359. doi: 10.1016/j.echo.2014.08.021.

Wheeler DC, London GM, Parfrey PS, Block GA, Correa-Rotter R, Dehmel B, Drueke TB, Floege J, Kubo Y, Mahaffey KW, Goodman WG, Moe SM, Trotman M, Abdalla S, Chertow GM, Herzog CA; EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial Investigators. Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial. J Am Heart Assoc. 2014 Nov 17;3(6):e001363. doi: 10.1161/JAHA.114.001363.

Shroff GR, Heubner BM, Herzog CA. Incidence of acute coronary syndrome in the general Medicare population, 1992 to 2009: A real-world perspective. JAMA Intern Med. 2014 Oct;174(10):1689-90. doi: 10.1001/jamainternmed.2014.3446.

Nigwekar SU, Solid CA, Ankers E, Malhotra R, Eggert W, Turchin A, Thadhani RI, Herzog CA. Quantifying a rare disease in administrative data: The example of calciphylaxis. J Gen Intern Med. 2014 Aug;29 Suppl 3(Suppl 3):S724-31. doi: 10.1007/s11606-014-2910-1.

Herzog CA, Shroff GR. Atherosclerotic versus nonatherosclerotic evaluation: The yin and yang of cardiovascular imaging in advanced chronic kidney disease. JACC Cardiovasc Imaging. 2014 Jul;7(7):729-32. doi: 10.1016/j.jcmg.2013.12.016.

Shroff GR, Solid CA, Herzog CA. Atrial fibrillation, stroke, and anticoagulation in Medicare beneficiaries: Trends by age, sex, and race, 1992-2010. J Am Heart Assoc. 2014 Jun 3;3(3):e000756. doi:10.1161/JAHA.113.000756.

Chawla LS, Herzog CA, Costanzo MR, Tumlin J, Kellum JA, McCullough PA, Ronco C, for the ADQI XI Workgroup. Proposal for a functional classification system of heart failure in patients with end-stage renal disease: Proceedings of the acute dialysis quality initiative (ADQI) XI workgroup. J Am Coll Cardiol. 2014;63:1246-1252.2014 Apr 8;63(13):1246-1252. doi: 10.1016/j.jacc.2014.01.020.

Kalra A, Shroff GR, Erlien D, Gilbertson DT, Herzog CA. Perflutren-based echocardiographic contrast in patients with right-to-left intracardiac shunts. JACC Cardiovasc Imaging. 2014 Feb;7(2):206-7. doi: 10.1016/j.jcmg.2013.11.003.

Shroff GR, Herzog CA. Acute myocardial infarction in patients with chronic kidney disease: How are the most vulnerable patients doing? Kidney Int. 2013 Aug;84(2):230-3. doi: 10.1038/ki.2013.151.

Shroff GR, Solid CA, Herzog CA. Long-term survival and repeat coronary revascularization in dialysis patients after surgical and percutaneous coronary revascularization with drug-eluting and bare metal stents in the United States. Circulation. 2013 May 7;127(18):1861-9. doi: 10.1161/CIRCULATIONAHA.112.001264.

Shroff GR, Herzog CA. Echocardiography: Providing additional insight into cardiovascular structural and functional abnormalities in advanced CKD. Clin J Am Soc Nephrol. 2013 Mar;8(3):339-41. doi: 10.2215/CJN.00370113.

Shroff GR, Solid CA, Herzog CA. Temporal trends in ischemic stroke and anticoagulation therapy among Medicare patients with atrial fibrillation: A 15-year perspective (1992-2007). JAMA Intern Med. 2013 Jan 28;173(2):159-60. doi: 10.1001/jamainternmed.2013.1579.

The EVOLVE Trial Investigators, Chertow GM, Block GA, Correa-Rotter R, Drueke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Trotman ML, Wheeler DC, Parfrey PS. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med. 2012 Dec 27;367(26):2482-94. doi: 10.1056/NEJMoa1205624.                          

Charytan DM, Li S, Liu J, Herzog CA. Risks of death and end-stage renal disease after surgical compared with percutaneous coronary revascularization in elderly patients with chronic kidney disease. Circulation. 2012 Sep 11;126(11 Suppl 1):S164-9. doi: 10.1161/CIRCULATIONAHA.111.083568.

Shroff GR, Frederick PD, Herzog CA. Renal failure and acute myocardial infarction: Clinical characteristics in patients with advanced chronic kidney disease, on dialysis, and without chronic kidney disease. A collaborative project of the United States Renal Data System/National Institutes of Health and the National Registry of Myocardial Infarction. Am Heart J. 2012 Mar;163(3):399-406. doi: 10.1016/j.ahj.2011.12.002.

Brenden CK, Eckman PM, Bruce-Fane L, Erlien D, Herzog CH. Atropine augmentation of treadmill exercise stress echocardiography. Echocardiography. 2011 Nov;28(10):1109-12. doi: 10.1111/j.1540-8175.2011.01482.x. 

Herzog CA, Asinger RW, Berger AK, Charytan DM, Díez J, Hart RG, Eckardt KU, Kasiske BL, McCullough PA, Passman RS, DeLoach S, Pun PH, Ritz E. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2011 Sep;80(6):572-86. doi: 10.1038/ki.2011.223.

Sharma A, Gilbertson DT, Herzog CA. Survival of kidney transplantation patients in the United States after cardiac valve replacement. Circulation. 2010 Jun 29;121(25):2733-9. doi: 10.1161/CIRCULATIONAHA.109.912170.

Shroff GR, Li S, Herzog CA. Survival of patients on dialysis having off-pump versus on-pump coronary artery bypass surgery in the United States. J Thorac Cardiovasc Surg. 2010 May;139(5):1333-8.  doi: 10.1016/j.jtcvs.2009.08.021.

Herzog CA. Incidence of adverse events associated with use of perflutren contrast agents for echocardiography. JAMA. 2008 May 7;299(17):2023-5. doi: 10.1001/jama.299.17.2023.

Herzog CA, Littrell K, Arko C, Frederick PD, Blaney M. Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: A collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction. Circulation. 2007 Sep 25;116(13):1465-72. doi: 10.1161/CIRCULATIONAHA.107.696765.

Lakshminarayan K, Solid CA, Collins AJ, Anderson DC, Herzog CA. Atrial fibrillation and stroke in the general Medicare population: A 10-year perspective (1992 to 2002). Stroke. 2006 Aug;37(8):1969-74. doi: 10.1161/01.STR.0000230607.07928.17.

Herzog CA, Li S, Weinhandl ED, Strief JW, Collins AJ, Gilbertson DT. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int. 2005 Aug;68(2):818-25. doi: 10.1111/j.1523 1755.2005.00462.x.

Ishani A, Weinhandl E, Zhao Z, Gilbertson DT, Collins AJ, Yusuf S, Herzog CA. Angiotensin-converting enzyme inhibitor as a risk for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction. J Am Coll Cardiol. 2005 Feb 1;45(3):391-9. doi: 10.1016/j.jacc.2004.10.038.

Herzog CA, Ma JZ, Collins AJ. Long-term outcome of renal transplant recipients in the United States after coronary revascularization procedure. Circulation. 2004 Jun 15;109(23):2866-71. doi: 10.1161/01.CIR.0000129317.12580.68.

Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation. 2002 Dec 3;106(23):2941-5. doi: 10.1161/01.cir.0000041254.30637.34.

Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation. 2002 Oct 22;106(17):2207-11. doi: 10.1161/01.cir.0000035248.71165.eb.

Chavers B, Li S, Collins A, Herzog CA. Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int. 2002 Aug;62(2):648-53. doi: 10.1046/j.1523-1755.2002.00472.x.

Herzog CA, Ma JZ, Collins AJ. Long-term survival of dialysis patients in the United States with prosthetic heart valves: Should ACC/AHA practice guidelines on valve selection be modified?  Circulation. 2002 Mar 19;105(11):1336-41. doi: 10.1161/hc1102.100075.

Herzog CA, Ma JZ, Collins AJ. Long-term outcome of dialysis patients in the United States with coronary revascularization procedures. Kidney Int. 1999 Jul;56(1):324-32. doi: 10.1046/j.1523-1755.1999.00540.x.

Posters & Presentations

Mortality and Hospitalization Following Initiation of Sacubitril/Valsartan in the Medicare Population. Nicholas S. Roetker, Yi Peng, William Eggert, David T. Gilbertson. Presented at the International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 2019.

Trends in Sudden Cardiac Death as a Proportion of Total Cardiovascular Mortality in Prevalent Hemodialysis Patients. Charles Herzog, Peer Kidney Care Initiative Investigators. Presented at the National Kidney Foundation Spring Clinical Meeting, 2017.

Readmissions, Other Healthcare Encounters, and Death after Admission for Cardiovascular Events in Hemodialysis Patients. James B. Wetmore, Peer Kidney Care Initiative Investigators. Presented at the National Kidney Foundation Spring Clinical Meeting, 2017.

Cardiovascular Event Rates after Myocardial Infarction or Ischemic Stroke in Older Medicare Patients. Suying Li, Yi Peng, Xinyue Wang, Yi Qian, Pin Xiang, Sally W. Wade, Haifeng Guo, J. Antonio G. Lopez, Yehuda Handelsman, Charles A. Herzog. Presented at the American Heart Association Scientific Sessions, 2017.

Statin Use and Dose by Low-Density Lipoprotein Cholesterol Level in a Commercially Insured Population of Secondary Prevention Patients. Anne Beaubrun, Jill Hardin, Deborah Kim, Katherine Mues, Keri Monda, Paul Muntner, Robert Rosenson, Charles Herzog. Presented at the American College of Cardiology Annual Meeting, 2016.

Underutilization of Statin Therapy after a Cardiovascular Event or Diabetes Diagnosis in Three Real-World Data Systems. Deborah Kim, Yi Peng, Suying Li, Jill Hardin, Anne Beaubrun, Katherine Mues, Brian Bradbury, Keri Monda, Paul Muntner, Robert S. Rosenson, Charles A. Herzog. Presented at the American College of Cardiology Annual Meeting, 2016.

Statin Use and Titration Patterns in the First Year Following a Cardiovascular Event in Commercially Insured Populations. Anne C. Beaubrun, Keri L. Monda, Deborah Kim, Katherine Mues, Brian D. Bradbury Robert S. Rosenson, Paul Muntner, Charles A. Herzog. Presented at the American Heart Association Scientific Sessions, 2016.

Statin Use and Titration Patterns in the First Year Following a T2DM Diagnosis in Commercially Insured Populations. Anne C. Beaubrun, Keri L. Monda, Deborah Kim, Katherine Mues, Charles A. Herzog, Robert S. Rosenson. Presented at the American Heart Association Scientific Sessions, 2016.

Comparative Utilization of Cardiac Stress Testing in US Patients with and without Chronic Kidney Disease. Charles A. Herzog, Tanya Natwick, Shuling Li, David M. Charytan . Presented at the American Heart Association Scientific Sessions, 2016.

Differential Outcome of Medical Therapy Compared with PCI and CABG in Individuals with CKD at Low, Medium, or High Cardiovascular Risk. Charles A. Herzog CA, Shuling Li, Tanya Natwick, Craig Solid, David M. Charytan. Presented at the American Heart Association Scientific Sessions, 2016.

Temporal Trends in Ischemic Stroke and Anticoagulation Therapy among Medicare Beneficiaries with Non-Valvular Atrial Fibrillation with and without Diabetes Mellitus, 1992-2010. Gautam R. Shroff, Craig A. Solid, Charles A. Herzog. Presented at the American Heart Association Scientific Sessions, 2014.

Statin Prescription and Dose Intensity among Elderly Medicare Beneficiaries, by Cardiovascular Disease Diagnosis and Prescriber Specialty. Akeem A. Yusuf, Christopher Wiggenhorn, Jill Hardin, Ryan Kilpatrick, Charles A. Herzog. Presented at the American Heart Association Scientific Sessions, 2014.

Publications

Loomba R, Wong R, Fraysse J, Shreay S, Li S, Harrison S, Gordon SC. Editorial: How widespread and serious is non-alcoholic fatty liver disease in the real world? Authors' reply. Aliment Pharmacol Ther. 2020 Jun;51(11):1200-1201. doi: 10.1111/apt.15724. PMID: 32424927.

Loomba R, Wong R, Fraysse J, Shreay S, Li S, Harrison S, Gordon SC. Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: A real world analysis of Medicare data. Aliment Pharmacol Ther. 2020 Jun;51(11):1149-1159. doi: 10.1111/apt.15679.

C Gordon S, Fraysse J, Li S, Ozbay AB, Wong RJ. Disease Severity Is Associated With Higher Healthcare Utilization in Nonalcoholic Steatohepatitis Medicare Patients. Am J Gastroenterol. 2020 Apr;115(4):562-574. doi: 10.14309/ajg.0000000000000484. 

Solid CA, Peter SA, Natwick T, Guo H, Collins AJ, Arduino JM. Impact of renal disease on patients with hepatitis C: A retrospective analysis of disease burden, clinical outcomes, and health care utilization and cost. Nephron. 2017;136(2):54-61. doi: 10.1159/000454684.

Israni AK, Xiong H, Liu J, Salkowski N, Trotter JF, Snyder JJ, Kasiske BL. Predicting end-stage renal disease after liver transplant. Am J Transplant. 2013 Jul;13(7):1782-92. doi: 10.1111/ajt.12257.

Posters & Presentations

Prevalence of Hepatitis C Virus (HCV) Infection and Associated Comorbidities in the 2008-2014 US Hemodialysis Population. Suying Li, Tingting Gong, Yi Peng, Kimberly M. Nieman, and David T. Gilbertson. Presented at the American Association for the Study of Liver Diseases, Liver Meeting, 2018.

Increasing Healthcare Resource Utilization (HCRU) and Costs Associated with Advanced Liver Disease – a Multivariate Analyses of Real-World Medicare Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) Patients. Gordon S, Fraysse J, Li S, Wong R. Presented at the American Association for the Study of Liver Diseases, Liver Meeting, 2018.

Increased Risk of Mortality in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) Patients: Real-World Analysis of 2007-2015 Medicare Data. Loomba R, Fraysse J, Li S, Harrison S. Presented at the American Association for the Study of Liver Diseases, Liver Meeting, 2018.

Substantial Healthcare Utilization (HCU) and Costs among Nonalcoholic Steatohepatitis (NASH) Patients with Comorbid Diabetes Mellitus (DM): Real-World Analysis of 2007-2015 US Medicare Data. Gordon, S. Li, Y. Peng, X. Wang X, R. Wong. Presented at the European Association for the Study of the Liver, International Liver Conference, 2018.

Health Care Costs are Double for Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH) Patients with Compensated Cirrhosis (CC) Who Progress to End-Stage Liver Disease (ESLD). Loomba, S. Li, Y. Peng, X. Wang, S. Harrison. Presented at the European Association for the Study of the Liver, International Liver Conference, 2018.

Sofosbuvir-Based Therapy is Associated with Higher Incidence of De-Registration for Clinical Improvement in Hepatitis C Patients Awaiting Liver Transplantation: An Analysis of SRTR-Symphony Database. Ray Kim, Beth Dellay, Jeffrey H. Wang, Yi Peng, Anne Sexter, Ajay Israni. Presented at the American Association for the Study of Liver Diseases, Liver Meeting, 2017.

Publications

Mahmood SB, Ji Y, Peng Y, Abou Zahr Z. Incidence of giant cell arteritis after bisphosphonate exposure: A retrospective cohort study. Int J Rheum Dis. 2021 Jan;24(1):63-68. doi: 10.1111/1756-185X.14018. 

Li S, Gong T, Peng Y, Nieman KM, Gilbertson DT. Prevalence and incidence of systemic lupus erythematosus and associated outcomes in the 2009-2016 Medicare population. Lupus. 2020 Jan;29(1):15-26. doi: 10.1177/0961203319888691.

Posters & Presentations

Treatment Patterns and Persistency Following the First Biologic DMARD in Patients with Rheumatoid Arthritis: Real-World Analysis of 2012–2016 US Medicare Data. Robin Dore, Lawrence Chang, Haifeng Guo, Suying Li, Jenya Antonova, Mark Genovese. Presented at: Academy of Managed Care Pharmacy (AMCP) Annual Meeting, 2019.

TNF Inhibitors: Prevalence of Use and Predictors of Treatment Non-Persistence in the 2011-2016 Medicare Population. Nicholas S. Roetker, Yi Peng, Kimberly M. Nieman, Suying Li, and David T. Gilbertson. Presented at the American College of Rheumatology, 2018. 

All-Cause Mortality, Hospitalization, and Systemic Lupus Erythematosus (SLE)-Related Complications in 2011-2015 Medicare Beneficiaries with SLE. Suying Li, Tingting Gong, Yi Peng, Kimberly M. Nieman, and David T. Gilbertson. Presented at the American College of Rheumatology, 2018.

Prevalence of Systemic Lupus Erythematosus (SLE) and Associated Comorbidity in the 2011-2015 Medicare Population. Suying Li, Tingting Gong, Yi Peng, Kimberly M. Nieman, and David T. Gilbertson. Presented at the American College of Rheumatology, 2018.

Prevalence of Rheumatoid Arthritis and Associated Comorbidities in the 2011-2015 Medicare Population. Suying Li, Julia T. Molony, Yi Peng, Kimberly M. Nieman, David T. Gilbertson. Presented at the American College of Rheumatology, 2017.

Publications

Hart A, Horak K, Roetker NS, Farnum A, Murray A, Johansen KL. Kidney function and physical performance decline: The Brain in Kidney Disease (BRINK) Cohort Study. Kidney Med. 2023 Dec 5;6(2):100770. doi: 10.1016/j.xkme.2023.100770. 

Wetmore JB, Johansen KL, Gilbertson DT, Roetker NS. Symptom trajectories in the electronic health record during the transition to maintenance dialysis. Clin J Am Soc Nephrol. 2023 Nov 14;19(1):101–7. doi: 10.2215/CJN.0000000000000371. 

Knapp CD, Li S, Kou C, Gilbertson DT, Weinhandl ED, Wetmore JB, Hart A, Johansen KL. Increased access, persistent disparities: Trends in disparities in peritoneal dialysis (PD) use, 2009-2019. Clin J Am Soc Nephrol. 2023 Nov 1;18(11):1483-1489. doi: 10.2215/CJN.0000000000000222.

Weinhandl ED, Eggert W, Hwang Y, Gilbertson DT, Petersen J. Contemporary practice of anemia treatment among dialysis patients in the United States. Kidney Int Rep. 2023 Sep 7;8(12):2616-2624. doi: 10.1016/j.ekir.2023.09.009. 

Johansen KL, Li S, Liu J, Weinhandl ED, Gilbertson DT, Kou I, Knapp C, Wetmore JB. Association of the End-Stage Renal Disease Treatment Choices payment model with home dialysis use at kidney failure onset from 2016 to 2022. JAMA Netw Open. 2023 Feb 1;6(2):e230806. doi: 10.1001/jamanetworkopen.2023.0806.

Roetker NS, Guo H, Ramey DR, McMullan CJ, Atkins GB, Wetmore JB. Hemodialysis access type and access patency loss: An observational cohort study. Kidney Med. 2022 Nov 5;5(1):100567. eCollection 2023 Jan. doi: 10.1016/j.xkme.2022.100567.

Wetmore JB, Weinhandl ED, Yan H, Reyes JL, Herzog CA, Roetker NS. Apixaban dosing patterns versus warfarin in patients with nonvalvular atrial fibrillation receiving dialysis: A retrospective cohort study. Am J Kidney Dis. 2022 Nov;80(5):569-579.e1. doi: 10.1053/j.ajkd.2022.03.007.

Weinhandl ED, Liu J, Gilbertson DT, Wetmore JB, Johansen KL. Associations of COVID-19 outcomes with dialysis modalities and settings. Clin J Am Soc Nephrol. 2022 Oct;17(10):1526-1534. doi: 10.2215/CJN.03400322. 

Roetker NS, Guo H, Ramey DR, McMullan CJ, Atkins GB, Wetmore JB. Hemodialysis vascular access and risk of major bleeding, thrombosis, and cardiovascular events: A cohort study. Kidney Med. 2022 Mar 24;4(6):100456. eCollection 2022 Jun. doi: 10.1016/j.xkme.2022.100456.

Roetker NS, Gilbertson DT, Weinhandl ED. A brief introduction on competing risks in the context of kidney disease epidemiology. Kidney360. Apr 2022;3(4):740-743. doi: 10.34067/KID.0007382021.

Liu J, Guo H, Lin T-C, Wetmore JB, Bradbury BD, Gilbertson DT, Nieman K, Peng Y, Sprafka JM, Dluzniewski PJ. Cinacalcet and gastrointestinal bleeding risk in patients receiving hemodialysis. Pharmacopepidemiol Drug Saf. 2022 Feb;31(2):141-148. doi: 10.1002/pds.5337.

Reyes JL, Herzog CA, Yan H, Roetker NS, Wetmore JB. Prescribing patterns of direct-acting oral anticoagulants in patients with atrial fibrillation and chronic kidney disease: A retrospective cohort analysis. J Cardiovasc Pharmacol Ther. 2022 Jan-Dec;27:10742484221142220. doi: 10.1177/10742484221142220.

Wetmore JB, Yan H, Herzog CA, Weinhandl E, Reyes JL, Roetker NS. CKD progression in Medicare beneficiaries with nonvalvular atrial fibrillation treated with apixaban versus warfarin. Am J Kidney Dis. 2021 Aug;78(2):180-189. doi: 10.1053/j.ajkd.2020.12.004. 

Weinhandl ED, Wetmore JB, Peng Y, Liu J, Gilbertson DT, Johansen KL. Initial effects of COVID-19 on patients with ESKD. J Am Soc Nephrol. 2021 Jun 1;32(6):1444-1453. doi: 10.1681/ASN.2021010009.

Wetmore JB, Yan H, Horne L, Peng Y, Gilbertson DT. Risk of hyperkalemia from renin-angiotensin-aldosterone system inhibitors and factors associated with treatment discontinuities in a real-world population. Nephrol Dial Transplant. 2021 Apr 26;36(5):826-839. doi: 10.1093/ndt/gfz263.

Gilbertson DT, Yan H, Xu H, Sinsakul M, Peng Y, Wetmore JB, Liu J, Li S. Development and validation of a transfusion risk score for patients receiving maintenance hemodialysis. Kidney360. 2021 Apr 9;2(6):948-954. doi: 10.34067/KID.0004512020.

Roetker NS, Guo H, Decker-Palmer MR, Peng Y, Wetmore JB. Changes in hemodialysis catheter management after introduction of the end-stage renal disease prospective payment system. BMC Nephrol. 2021 Jan 6;22(1):8. doi: 10.1186/s12882-020-02222-9.

Wetmore JB, Ji Y, Ashfaq A, Gilbertson DT, Roetker NS. Testing Patterns for CKD-MBD Abnormalities in a Sample US Population. Kidney Int Rep. 2021 Jan 6;6(4):1141-1150. doi: 10.1016/j.ekir.2020.12.036.

Zhao JZ, Weinhandl ED, Carlson AM, St. Peter WL. Glucose-lowering medication use in CKD: Analysis of US Medicare beneficiaries between 2007 and 2016. Kidney Med. 2020 Dec 30;3(2):173-182.e1. doi: 10.1016/j.xkme.2020.09.016. 

Wetmore JB, Herzog CA, Sexter A, Gilbertson DT, Liu J, Kasner SE. Outcomes following ischemic stroke in older patients with CKD stages 4 and 5: A retrospective cohort study. Am J Kidney Dis. 2020 Dec;76(6):784-793. doi: 10.1053/j.ajkd.2020.03.021.

Wetmore JB, Roetker NS, Herzog CA. Response by Wetmore et al to letter regarding article, “Direct-acting oral anticoagulants versus warfarin in Medicare patients with chronic kidney disease and atrial fibrillation”. Stroke. 2020 Dec;51(12):e363-e364. doi: 10.1161/STROKEAHA.120.032181.  

Weinhandl ED, Gilbertson DT. Relative survival with peritoneal dialysis: The hunt for a comparator continues. Kidney Med. 2020 Nov 4;2(6):678-680. doi: 10.1016/j.xkme.2020.11.001.

Wetmore JB. Calcimimetics: A promise unfulfilled. Am J Kidney Dis. 2020 Sep;76(3):308-310. doi: 10.1053/j.ajkd.2020.03.018.

Wetmore JB, Roetker NS, Yan H, Reyes JL, Herzog CA. Direct-acting oral anticoagulants versus warfarin in Medicare patients with chronic kidney disease and atrial fibrillation. Stroke. 2020 Aug;51(8):2364-2373. doi: 10.1161/STROKEAHA.120.028934.

Wetmore JB. Pruritis: A vexing problem with a promising new therapy. Kidney Int Rep. 2020 Mar 18;5(5):577-579. doi: 10.1016/j.ekir.2020.03.015.

Li S, Liu J, Dluzniewski PJ, Wetmore JB, Gilbertson DG, Bradbury BD. Association of hospital transfusion use and infection-related rehospitalizations among patients receiving hemodialysis: A retrospective cohort study. Hemodial Int. 2020 Jan;24(1):79-88. doi: 10.1111/hdi.12809.

Wetmore JB, Yan H, Gilbertson DT, Liu J. Factors associated with elective withdrawal of maintenance hemodialysis: A case-control analysis. Am J Nephrol. 2020;51(3):227-236. doi: 10.1159/000505993.

Wetmore JB, Li S, Ton TGN, Peng Y, Hansen MK, Neslusan C, Riley R, Liu J, Gilbertson DT. Association of diabetes-related kidney disease with cardiovascular and non-cardiovascular outcomes: A retrospective cohort study. BMC Endocr Disord. 2019 Aug 27;19(1):89. doi: 10.1186/s12902-019-0417-9.

Wang CJ, Johansen KL. Are dialysis patients too frail to exercise? Semin Dial. 2019 Jul;32(4):291-296. doi: 10.1111/sdi.12786.

Wetmore JB, Roetker NS, Gilbertson DT, Liu J. Early withdrawal and non-withdrawal death in the months following hemodialysis initiation: A retrospective cohort analysis. Hemodial Int. 2019 Apr;23(2):261-272. doi: 10.1111/hdi.12723. 

Gilbertson DT, Rothman KJ, Chertow GM, Bradbury BD, Brookhart MA, Liu J, Winkelmayer WC, Stürmer T, Monda KL, Herzog CA, Ashfaq A, Collins AJ, Wetmore JB. Excess deaths attributable to influenza-like illness in the ESRD population. J Am Soc Nephrol. 2019 Feb;30(2):346-353. doi: 10.1681/ASN.2018060581.

Roetker NS, Peng Y, Ashfaq A, Gilbertson DT, Wetmore JB. Adherence to kidney disease: Improving global outcomes mineral and bone guidelines for monitoring biochemical parameters. Am J Nephrol. 2019;49(3):225-232. doi: 10.1159/000497477.

Wetmore JB, Li S, Yan H, Xu H, Peng Y, Sinsakul MV, Liu J, Gilbertson DT. Predialysis anemia management and outcomes following dialysis initiation: A retrospective cohort analysis. PLOS One. 2018 Sep 26;13(9):e0203767. doi: 10.1371/journal.pone.0203767. 

Eidman KE, Wetmore JB. Treatment of secondary hyperparathyroidism: How do cinacalcet and etelcalcetide differ? Semin Dial. 2018 Sep;31(5):440-444. doi: 10.1111/sdi.12734.

Wetmore JB, Yan H, Hu Y, Gilbertson DT, Liu J. Factors associated with withdrawal from maintenance dialysis: A case-control analysis. Am J Kidney Dis. 2018 Jun;71(6):831-841. doi: 10.1053/j.ajkd.2017.10.025.

Collins AC, Kliger AS. Urgent: Stop preventable infections now. Clin J Am Soc Nephrol. 2018 Apr 6;13(4):663-665. doi: 10.2215/CJN.10790917.

St Peter WL, Guo H, Kabadi S, Gilbertson DT, Peng Y, Pendergraft T, Li S. Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the US. BMC Nephrol. 2018 Mar 15;19(1):67. doi: 10.1186/s12882-018-0861-1.

Wetmore JB, Li, S, Molony JT, Guo H, Herzog CA, Gilbertson DT, Peng Y, Collins AJ. Insights from the 2016 Peer Kidney Care Initiative Report: Still a ways to go to improve care for dialysis patients. Am J Kidney Dis. 2018 Jan;71(1):123-132. doi: 10.1053/j.ajkd.2017.08.023.

Gilbertson DT, Hu Y, Peng Y, Maroni BJ, Wetmore JB. Variability in hemoglobin levels in hemodialysis patients in the current era: A retrospective cohort study. Clin Nephrol. 2017 Nov;88(11):254-265. doi: 10.5414/CN109031.

Wetmore JB, Liu J, Li S, Hu Y, Peng Y, Gilbertson DT, Collins AJ. The Healthy People 2020 objectives for kidney disease: How far have we come, and where do we need to go? Clin J Am Soc Nephrol. 2017 Jan 6;12(1):200-209. doi: 10.2215/CJN.04210416.

Wang CJ, Wetmore JB, Israni AK. Old versus new: Progress in reaching the goals of the new kidney allocation system. Hum Immunol. 2017 Jan;78(1):9-15. doi: 10.1016/j.humimm.2016.08.007.

Solid CA, Peter SA, Natwick T, Guo H, Collins AJ, Arduino JM. Impact of renal disease on patients with hepatitis C: A retrospective analysis of disease burden, clinical outcomes, and health care utilization and cost. Nephron. 2017;136(2):54-61. doi: 10.1159/000454684.

Liu J, Krishnan M, Zhou J, Nieman KM, Peng Y, Gilbertson DT. Data completeness as an unmeasured confounder in dialysis facility performance comparison with 1-year follow-up. Clin Nephrol. 2016 Nov;86 (2016)(11):262-269. doi: 10.5414/CN108816.

Chertow GM, Liu J, Monda KL, Gilbertson DT, Brookhart MA, Beaubrun AC, Winkelmayer WC, Pollack A, Herzog CA, Ashfaq A, Sturmer T, Rothman KJ, Bradbury BD, Collins AJ. Epoetin alfa and outcomes in dialysis patients amid regulatory and payment reform. J Am Soc Nephrol. 2016 Oct;27(10):3129-3138. doi: 10.1681/ASN.2015111232.

Wetmore JB, Guo H, Gilbertson DT, Collins AJ. The incidence, prevalence, and outcomes of glomerulonephritis derived from a large retrospective analysis. Kidney Int. 2016 Oct;90(4):853-60. doi: 10.1016/j.kint.2016.04.026.

Molony JT, Monda KL, Li S, Beaubrun AC, Gilbertson DT, Bradbury BD, Collins AJ. Effects of epoetin alfa titration practices, implemented after changes to product labeling, on hemoglobin levels, transfusion use, and hospitalization rates. Am J Kidney Dis. 2016 Aug;68(2):266-276. doi: 10.1053/j.ajkd.2016.02.038. 

Wetmore JB, Gilbertson DT, Liu J, Collins AJ. Improving outcomes in patients receiving dialysis: The Peer Kidney Care Initiative. Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1297-304. doi: 10.2215/CJN.12981215.

Wetmore JB, Tzivelekis S, Collins AJ, Solid CA. Effects of the prospective payment system on anemia management in maintenance dialysis patients: Implications for cost and site of care. BMC Nephrol. 2016 May 26;17(1):53. doi: 10.1186/s12882-016-0267-x.

Wetmore JB, Collins AJ. Global challenges posed by the growth of end-stage renal disease. Renal Replac Ther. 2016 Feb;2:15. doi: 10.1186/s41100-016-0021-7.

Wetmore JB, Peng Y, Jackson S, Matlon TJ, Collins AJ, Gilbertson DT. Patient characteristics, disease burden, and medication use in stage 4-5 chronic kidney disease patients. Clin Nephrol. 2016 Feb;85(2):101-11. doi: 10.5414/CN108626.

Weinhandl ED, Gilbertson DT, Collins AJ. Mortality, hospitalization, and technique failure in daily home hemodialysis and matched peritoneal dialysis patients: A matched cohort study. Am J Kidney Dis. 2016 Jan;67(1):98-110. doi: 10.1053/j.ajkd.2015.07.014.

Wetmore JB, Gilbertson DT, Collins AJ. Shaping public health initiatives in kidney diseases: The Peer Kidney Care Initiative. Blood Purif. 2016;41(1-3):151-8. doi: 10.1159/000441316.

Gilbertson DT, Wetmore JB. Infections requiring hospitalization in hemodialysis patients. Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2101-3. doi: 10.2215/CJN.10891015.

Krishnan M, Weinhandl ED, Jackson S, Gilbertson DT, Lacson Jr E. Comorbidity ascertainment from the ESRD Medical Evidence Report and Medicare claims around dialysis initiation: A comparison using US Renal Data System data. Am J Kidney Dis. 2015 Nov;66(5):802-12. doi: 10.1053/j.ajkd.2015.04.015.

Wetmore JB, Collins AJ. Meeting the world’s need for maintenance dialysis. J Am Soc Nephrol. 2015 Nov;26(11):2601-3. doi: 10.1681/ASN.2015060660. 

St. Peter WL. Management of polypharmacy in dialysis patients. Semin Dial. 2015 Jul-Aug;28(4):427-32. doi: 10.1111/sdi.12377. 

Weinhandl ED, Nieman KM, Gilbertson DT, Collins AJ. Hospitalization in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. Am J Kidney Dis. 2015 Jan;65(1):98-108. doi: 10.1053/j.ajkd.2014.06.015.

Wetmore JB, Peng Y, Monda KL, Kats AM, Kim DH, Bradbury BD, Collins AJ, Gilbertson DT. Trends in anemia management practices in patients receiving hemodialysis and peritoneal dialysis: A retrospective cohort analysis. Am J Nephrol. 2015;41(4-5):354-61. doi: 10.1159/000431335.

Liu J, Li S, Gilbertson DT, Monda KL, Bradbury BD, Collins AJ. Development of a standardized transfusion ratio as a metric for evaluating dialysis facility anemia management practices. Am J Kidney Dis. 2014 Oct;64(4):608-15. doi: 10.1053/j.ajkd.2014.04.012. 

Hakim RM, Collins AJ. Reducing avoidable rehospitalization in ESRD: A shared accountability. J Am Soc Nephrol. 2014 Sep;25(9):1891-3. doi: 10.1681/ASN.2014030270. 

Collins AJ, Molony J, Li S, Monda KL, Gilbertson DT, Bradbury BD. Effect of facility-level hemoglobin concentration on dialysis patient risk of transfusion. Am J Kidney Dis. 2014 Jun;63(6):997-1006. doi: 10.1053/j.ajkd.2013.10.052.

Slinin Y, Guo H, Li S, Liu J, Morgan B, Ensrud K, Gilbertson DT, Collins AJ, Ishani A. Provider and care characteristics associated with timing of dialysis initiation. Clin J Am Soc Nephrol. 2014 Feb;9(2):310-7. doi: 10.2215/CJN.04190413.

Foley RN, Solid CA, Lamb K. Perihospitalization patterns of hemoglobin levels and erythropoiesis-stimulating agent doses in US hemodialysis patients, 1998-2009. Hemodial Int. 2014 Jan;18(1):24-31. doi: 10.1111/hdi.12090. 

Ishani A, Gilbertson DT, Kim D, Bradbury BD, Collins AJ. Predialysis care and dialysis outcomes in hemodialysis patients with a functioning fistula. Am J Nephrol. 2014;39(3):238-47. doi: 10.1159/000358843.

Slinin Y, Guo H, Li S, Liu J, Ensrud K, Gilbertson DT, Collins AJ, Ishani A. Hemodialysis patient outcomes: Provider characteristics. Am J Nephrol. 2014;39(5):367-75. doi: 10.1159/000362286.

St. Peter WL, Shafi T, Sozio SM, Luly J, Bandeen-Roche K, Ephraim PL, Michels W, Crews DC, Miskulin DC, Jaar BG, Wu A, Boulware LE, for the DEcIDE Network. Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months. BMC Nephrol. 2013 Nov 12;14:249. doi: 10.1186/1471-2369-14-249.

Gilbertson DT, Monda KL, Bradbury BD, Collins AJ. RBC transfusions among hemodialysis patients (1999-2010): Influence of hemoglobin concentrations below 10 g/dL. Am J Kidney Dis. 2013 Nov;62(5):919-28. doi: 10.1053/j.ajkd.2013.05.004.

St. Peter WL, Wazny LR, Patel U. New models of chronic kidney disease care including pharmacists: Improving medication reconciliation and medication management. Curr Opin Nephrol Hypertens. 2013 Nov;22(6):656-62. doi: 10.1097/MNH.0b013e328365b364.

Weinhandl ED, Arneson TJ, St. Peter WL. Clinical outcomes associated with receipt of integrated pharmacy services by hemodialysis patients: A quality improvement report. Am J Kidney Dis. 2013 Sep;62(3):557-67. doi: 10.1053/j.ajkd.2013.02.360.

St. Peter WL, Odum LE, Whaley-Connell AT. To RAS or not to RAS? The evidence for and cautions with renin-angiotensin system inhibition in patients with diabetic kidney disease. Pharmacotherapy. 2013 May;33(5):496-514. doi: 10.1002/phar.1232. 

St. Peter WL, Weinhandl ED, Flessner MF. Sitagliptin—another option for managing type 2 diabetes in dialysis patients? Am J Kidney Dis. 2013 Apr;61(4):532-5. doi: 10.1053/j.ajkd.2013.01.004.

Gilbertson DT, Peng Y, Arneson TJ, Dunning S, Collins AJ. Comparison of methodologies to define hemodialysis patients hyporesponsive to epoetin and impact on counts and characteristics. BMC Nephrol. 2013 Feb 20;14:44. doi: 10.1186/1471-2369-14-44.

Slinin Y, Guo H, Li S, Liu J, Morgan B, Ensrud K, Gilbertson DT, Collins AJ, Ishani A. Predictors of provider-patient visit frequency during hemodialysis. Am J Nephrol. 2013;38(2):91-8. doi: 10.1159/000353565. 

Slinin Y, Guo H, Li S, Liu J, Ensrud K, Gilbertson DT, Collins AJ, Ishani A. Association of provider-patient visit frequency and patient outcomes on hemodialysis. J Am Soc Nephrol. 2012 Sep;23(9):1560-7. doi: 10.1681/ASN.2012010051.

Weinhandl ED, Liu J, Gilbertson DT, Arneson TJ, Collins AJ. Survival in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. J Am Soc Nephrol. 2012 May;23(5):895-904. doi: 10.1681/ASN.2011080761.

Gilbertson DT, Guo H, Arneson TJ, Collins AJ. The association of pneumococcal vaccination with hospitalization and mortality in hemodialysis patients. Nephrol Dial Transplant. 2011 Sep;26(9):2934-9. doi: 10.1093/ndt/gfq853.

Murray AM, Barzilay JI, Lovato JF, Williamson JD, Miller ME, Marcovina S, Launer LJ, for the Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes (ACCORD-MIND) Investigators. Biomarkers of renal function and cognitive impairment in patients with diabetes. Diabetes Care. 2011 Aug;34(8):1827-32. doi: 10.2337/dc11-0186. 

Kalirao P, Pederson SL, Robert N. Foley RN, Kolste A, Tupper DE, Zaun D, Vanessa Buot, Murray AM. Cognitive impairment in peritoneal dialysis patients. Am J Kidney Dis. 2011 Apr;57(4):612-20. doi: 10.1053/j.ajkd.2010.11.026.

Weinhandl ED, Peng Y, Gilbertson DT, Bradbury BD, Collins AJ. Hemoglobin variability and mortality: Confounding by disease severity. Am J Kidney Dis. 2011 Feb;57(2):255-65. doi: 10.1053/j.ajkd.2010.06.013.

Weinhandl ED, Gilbertson DT, Collins AJ. Association of mean weekly epoetin alfa dose with mortality risk in a retrospective cohort study of Medicare hemodialysis patients. Am J Nephrol. 2011;34(4):298-308. doi: 10.1159/000330693. 

Arneson TJ, Liu J, Qui Y, Gilbertson DT, Foley RN, Collins AJ. Hospital treatment for fluid overload in the Medicare hemodialysis population. Clin J Am Soc Nephrol. 2010 Jun;5(6):1054-63. doi: 10.2215/CJN.00340110.

Mau LW, Liu J, Qui Y, Guo H, Ishani A, Arneson TJ, Gilbertson DT, Dunning SC, Collins AJ. Trends in patient characteristics and first-year medical costs of older incident hemodialysis patients, 1995-2005. Am J Kidney Dis. 2010 Mar;55(3):549-57. doi:10.1053/j.ajkd.2009.11.014.

Weinhandl ED, Foley RN, Gilbertson DT, Arneson TJ, Snyder JJ, Collins AJ. Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol. 2010 Mar;21(3):499-506. doi: 10.1681/ASN.2009060635.

Foley RN, Roberts TL, Liu J, Gilbertson DT, Arneson TJ, Dunning S, Collins AJ. Mortality from cancer among US hemodialysis patients, 1995-2005. Am J Nephrol. 2010;31(6):518-26. doi: 10.1159/000303754.

Ibrahim HN, Ishani A, Guo H, Gilbertson DT. Blood transfusion use in nondialysis-dependent chronic kidney disease patients aged 65 years and older. Nephrol Dial Transplant. 2009 Oct;24(10):3138-43. doi: 10.1093/ndt/gfp213.

Liu J, Guo H, Gilbertson DT, Foley RN, Collins AJ. Associations of anemia persistency with medical expenditures in Medicare ESRD patients on dialysis. Ther Clin Risk Manag. 2009 Aug;5(4):319-30. doi: 10.2147/tcrm.s4856.

Ishani A, Guo H, Arneson TJ, Gilbertson DT, Mau LW, Li S, Dunning S, Collins AJ. Possible effects of the new Medicare reimbursement policy on African Americans with ESRD. J Am Soc Nephrol. 2009 Jul;20(7):1607-13. doi: 10.1681/ASN.2008080853.

Arneson TJ, Zaun D, Peng Y, Solid CA, Dunning S, Gilbertson DT. Comparison of methodologies to characterize haemoglobin variability in the US Medicare haemodialysis population. Nephrol Dial Transplant. 2009 May;24(5):1378-83. doi: 10.1093/ndt/gfp018.

Ibrahim HN, Foley RN, Zhang R, Gilbertson DT, Collins AJ. Parenteral iron use: Possible contribution to exceeding target hemoglobin in hemodialysis patients. Clin J Am Soc Nephrol. 2009 Mar;4(3):623-9. doi: 10.2215/CJN.03850808.

Collins AJ, Guo H, Gilbertson DT, Bradbury BD. Predictors of ESA use in the non-dialysis chronic kidney disease population with anemia. Nephron Clin Pract. 2009;111(2):c141-8. doi: 10.1159/000191207.

Gilbertson DT, Peng Y, Bradbury B, Ebben JP, Collins AJ. Hemoglobin level variability: Anemia management among variability groups. Am J Nephrol. 2009;30(6):491-8. doi: 10.1159/000243565.

Posters & Presentations

Impact of the CMS Payment Bundle for Hemodialysis Vascular Access. James B. Wetmore, Haifeng Guo, Marquita Decker-Palmer, Yi Peng, Nicholas S. Roetker. Presented at the National Kidney Foundation Spring Clinical Meeting, 2020.

Cinacalcet Use and Risk of Gastrointestinal Bleeding in Secondary Hyperparathyroidism Patients Receiving Maintenance Hemodialysis. Tzu-Chieh Lin, Haifeng Guo, Paul Dluzniewski, Yi Peng, David Gilbertson, Brian Bradbury, Kimberly Nieman, J. Michael Sprafka, Jiannong Liu. Presented at the 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 2019.

Economic Burden of Anemia-Related Transfusions in Medicare Dialysis Patients. David T. Gilbertson, Suying Li, Tara Matsuda, Yi Peng, Vasily Belozeroff, Nisha Bhatt, James B. Wetmore. Presented at the American Society of Nephrology Annual Meeting, 2018.

Trends in Hospitalization, Emergency Dept. Encounters, and Observation Stays in Prevalent Hemodialysis Patients. David T. Gilbertson, Peer Kidney Care Initiative Investigators. Presented at the National Kidney Foundation Spring Clinical Meeting, 2017.  

Patterns of Anemia Management in the Predialysis Period. James B. Wetmore, Heng Yan, David T. Gilbertson, Hairong Xu, Marvin V. Sinsakul, Yi Peng, Jiannong Liu, Suying Li. Presented at the American Society of Nephrology Annual Meeting, 2017.

Hospital Transfusion Use and Infection-Related Re-Hospitalization among Patients on Dialysis. David T. Gilbertson, Suying Li, Jiannong Liu, James B. Wetmore, Anne Beaubrun, Paul Dluzniewski, Xinyue Wang, Brian Bradbury. Presented at the National Kidney Foundation Spring Clinical Meeting, 2016. 

Cardiac Stress Testing in U.S. Patients with Chronic Kidney Disease: Is the Epoch of Nihilism and Renalism Ancient History? Charles A. Herzog, Tanya Natwick, Shuling Li, David M. Charytan. Presented at the American Society of Nephrology Annual Meeting, 2016.

High Dose Erythropoiesis-Stimulating Agent Is Associated with Increased Healthcare Resource Utilization and Risk of Adverse Events in Non-Dialysis-Dependent Chronic Kidney Disease Patients. David T. Gilbertson, Suying Li, Yi Peng, Haifeng Guo, Shaum Kabadi, Sean Zhao, Trudy Pendergraft, Louise Sargent Heuer, and Wendy L. St. Peter. Presented at the American Society of Nephrology Annual Meeting, 2016.

Unexpected Medical Consequences of Revised ESA Label in Non-Dialysis Dialysis-Dependent Chronic Kidney Disease Patients with Anemia. Suying Li, Haifeng Guo, Shaum Kabadi, Sean Zhao, Trudy Pendergraft, Louise Sargent Heuer, Yi Peng, Wendy St. Peter, David T. Gilbertson. Presented at the American Society of Nephrology Annual Meeting, 2016.

Anemia Prevalence and Treatment in Patients with Non-Dialysis-Dependent Chronic Kidney Disease. Wendy L. St. Peter, Haifeng Guo, Shaum Kabadi, Sean Zhao, David T. Gilbertson, Louise Sargent Heuer, Yi Peng, Trudy Pendergraft, Suying Li. Presented at the American Society of Nephrology Annual Meeting, 2016.

Anemia is Associated with Higher Healthcare Utilization and Costs in Non-Dialysis-Dependent Chronic Kidney Disease Patients. Suying Li, Haifeng Guo, Shaum Kabadi, Sean Zhao, David T. Gilbertson, Louise Sargent Heuer, Yi Peng, Trudy Pendergraft, Wendy L. St. Peter. Presented at the Academy of Managed Care Pharmacy, 2016.

Anemia Prevalence and Treatment Patterns in Non-Dialysis-Dependent Chronic Kidney Disease Patients Before and After Revised FDA Label and Anemia Guidelines for Erythropoiesis-Stimulating Agents. Wendy L. St. Peter, Haifeng Guo, Shaum Kabadi, Sean Zhao, David T. Gilbertson, Louise Sargent Heuer, Yi Peng, Trudy Pendergraft, Suying Li. Presented at the Academy of Managed Care Pharmacy, 2016.  

Anemia Prevalence and Treatment Rates in Stage 3-5 Non-Dialysis-Dependent Chronic Kidney Disease Patients. David T. Gilbertson, Suying Li, Yi Peng, Haifeng Guo, Shaum Kabadi, Sean Zhao, Trudy Pendergraft, Louise Sargent Heuer, Wendy L. St. Peter. Presented at the Academy of Managed Care Pharmacy, 2016.

Temporal Trends in Myocardial Infarction Incidence and 30-Day Mortality in U.S. Dialysis Patients. Charles A. Herzog, Keri L. Monda, Anne C. Beaubrun, Wolfgang C. Winkelmayer, Til Sturmer, Allan J. Collins, Akhtar Ashfaq, Kenneth J. Rothman, David T. Gilbertson. Presented at the American Society of Nephrology Annual Meeting, 2015.

Influenza and Outcomes in ESRD Patients. David T. Gilbertson, Anne C. Beaubrun, Kenneth J. Rothman, Jiannong Liu, Brian D. Bradbury, Akhtar Ashfaq, Charles A. Herzog, Allan J. Collins. Presented at the American Society of Nephrology Annual Meeting, 2015.

Variability in Hemoglobin (Hb) Levels in Hemodialysis (HD) Patients in the Current Era. Dave Gilbertson, Yan Hu, Yi Peng, Sarb Shergill, Bradley Maroni. Presented at the American Society of Nephrology Annual Meeting, 2015.

Comorbidity Data Source may Impact SMR/SHR Calculation. Jiannong Liu, Mahesh Krishnan, Jincheng Zhou, Kimberly Nieman, Yi Peng, David Gilbertson. Presented at the American Society of Nephrology Annual Meeting, 2015.

Trends in 30-Day Readmission Rates in Dialysis Patients during an Era of Medicare Payment Policy Changes, 1996-2012. Suying Li, Peer CMO group. Presented at the American Society of Nephrology Annual Meeting, 2015.

Increasing Prevalence of Withdrawal from Dialysis: Trends from 2004-2011. James Wetmore, Peer CMO group. Presented at the American Society of Nephrology Annual Meeting, 2015.

Trends in Incident ESRD Counts: Regional Variation in Initiating Dialysis in Freestanding Facilities. Dave Gilbertson, Peer CMO group. Presented at the American Society of Nephrology Annual Meeting, 2015. 

Frequency of Hyperkalemia Events in Dialysis Patients in a Large Dialysis Organization. Akeem Yusuf, Yan Hu, Bhupinder Singh, Alex Yang, James Wetmore. Presented at the American Society of Nephrology Annual Meeting, 2015.

Serum Potassium Levels and Mortality in Hemodialysis Patients. Akeem Yusuf, Yan Hu, Bhupinder Singh, Jose Menoyo, Alex Yang, James Wetmore. Presented at the American Society of Nephrology Annual Meeting, 2015.

30-Day Readmission Rates after Heart Failure and Hypertensive Disease Discharges in Daily Home Hemodialysis, Peritoneal Dialysis, and In-Center Hemodialysis Patients. Eric Weinhandl, Allan Collins. Presented at the National Kidney Foundation Spring Clinical Meeting, 2015.

Lower Risk of Early Death in Incident Dialysis Patients on Daily Home versus In-center Hemodialysis. Eric Weinhandl, Allan Collins. Presented at the National Kidney Foundation Spring Clinical Meeting, 2015.

Insufficient Risk Adjustment of Quality Metrics for a Niche Dialysis Provider. Eric Weinhandl, Steve Bucher. Presented at the National Kidney Foundation Spring Clinical Meeting, 2015.

Facility-Level CKD-MBD Composite Score and Risk of Adverse Clinical Outcomes among Patients on Hemodialysis. David Gilbertson, Yan Hu, Heidi Wirtz, Akeem Yusuf, Thy Do, Brian Bradbury, Kerry Cooper, Mark Danese, Allan Collins, Geoff Block. Presented at the National Kidney Foundation Spring Clinical Meeting, 2015.

Comorbidity Burden and Medication Use in Stage 4-5 CKD Patients. David T. Gilbertson, Yi Peng, Scott Jackson, Allan J. Collins. Presented at the National Kidney Foundation Spring Clinical Meeting, 2014.

Clinical Consequences Following Parathyroidectomy in a Nationwide Cohort of Patients on Hemodialysis. Areef Ishani, Jiannong Liu, James B. Wetmore, Kim Lowe, Thy Do, Brian D. Bradbury, Geoffrey A. Block, Allan J. Collins. Presented at the National Kidney Foundation Spring Clinical Meeting, 2014.

Patterns of Anemia Management in Patients Undergoing Peritoneal Dialysis. Yi Peng, Allyson Kats, David T. Gilbertson, Deborah Kim, Keri L. Monda, James B. Wetmore, Brian D. Bradbury, Allan J. Collins. Presented at the National Kidney Foundation Spring Clinical Meeting, 2014.

Characteristics Associated with Parathyroidectomy in Medicare Hemodialysis Patients. James B. Wetmore, Jiannong Liu, Kimberly A. Lowe, Areef Ishani, Thy P. Do, Brian D. Bradbury, Geoffrey A. Block, Allan J. Collins. Presented at the National Kidney Foundation Spring Clinical Meeting, 2014.

Prevalence of Glomerulonephritis in the U.S: Insights from a Large Administrative Dataset. James B. Wetmore, Haifeng Guo, David T. Gilbertson. Presented at the National Kidney Foundation Spring Clinical Meeting, 2014. 

Trends in Anemia Management in US Patients on Dialysis, 2005-2011. David T. Gilbertson, Anne C. Beaubrun, Jiannong Liu, Akhtar Ashfaq, Wolfgang C. Winkelmayer, Glenn M. Chertow, Allan J. Collins. Presented at the American Society of Nephrology Annual Meeting, 2014.

Facility EPO Titration Practices, Hemoglobin Levels, and Transfusion Use. Julia T. Molony, Keri L. Monda, Suying Li, Anne Beaubrun, David T. Gilbertson, Brian D. Bradbury, Allan J. Collins. Presented at the American Society of Nephrology Annual Meeting, 2014.

Geographic Variation in Fracture Incidence in US Patients Receiving Hemodialysis. James B. Wetmore, Jiannong Liu, Heidi S. Wirtz, Thy P. Do, David T. Gilbertson, Brian D. Bradbury, Allan J. Collins. Presented at the American Society of Nephrology Annual Meeting, 2014. 

Evaluating Observed vs. Expected Mortality Rates in US Dialysis Patients Amid Secular Declines. Jiannong Liu, Keri L. Monda, Charles A. Herzog, M. Alan Brookhart, Til Stürmer, Brian D. Bradbury, Kenneth J. Rothman, Glenn M. Chertow. Presented at the American Society of Nephrology Annual Meeting, 2014.

Changes in PTH, Calcium, and Phosphorous Levels after Parathyroidectomy in Patients on Hemodialysis. James B. Wetmore, Jiannong Liu, Thy P. Do, Kimberly A. Lowe, Areef Ishani, Brian D. Bradbury, Geoffrey A. Block, Allan J. Collins. Presented at the American Society of Nephrology Annual Meeting, 2014.

Prevalence of Glomerulonephritis in the U.S. Medicare Population. James B. Wetmore, Haifeng Guo, David T. Gilbertson. Presented at the American Society of Nephrology Annual Meeting, 2014.

Transfusion Events in Hemodialysis Patients by Hemoglobin Level, ESA Users vs. Non-ESA Users. Allan J. Collins, Tom Matlon, Yi Peng, David T. Gilbertson. Presented at the American Society of Nephrology Annual Meeting, 2014.

Lower Risks of Death and On-Treatment Hospitalization in DaVita Rx Members versus Matched Controls. Eric D. Weinhandl, Wendy L. St. Peter. Presented at the American Society of Nephrology Annual Meeting, 2014.

Increases in Medication Use after New Membership in DaVita Rx. Eric D. Weinhandl, Wendy L. St. Peter. Presented at the American Society of Nephrology Annual Meeting, 2014.

Lower Risk of Technique Failure in Daily Home Hemodialysis versus Peritoneal Dialysis Patients. Eric D. Weinhandl, David T. Gilbertson, Allan J. Collins. Presented at the American Society of Nephrology Annual Meeting, 2014. 

Lower Risk of Hospitalization in Daily Home Hemodialysis versus Peritoneal Dialysis Patients. Eric D. Weinhandl, Kimberly M. Nieman, David T. Gilbertson, Allan J. Collins. Presented at the American Society of Nephrology Annual Meeting, 2014. 

Differences in Medication Use among Daily Home Hemodialysis, Peritoneal Dialysis, and In-Center Hemodialysis Patients. Eric D. Weinhandl, David T. Gilbertson, Allan J. Collins. Presented at the American Society of Nephrology Annual Meeting, 2014.

Dialysis Facility-Level Transfusion Rates Can Be Unreliable Due to Variability in Hospital-Level Billing Patterns for Blood. Eric D. Weinhandl, David T. Gilbertson, Allan J. Collins. Presented at the American Society of Nephrology Annual Meeting, 2014.

Publications

Li S, Suehs BT, Fu A, Sangaré L, Kim C, Gastanaga VM, Liu J, Yan H, Xu Y, Mikhael J. Heart failure among patients with multiple myeloma treated with carfilzomib-based versus non–carfilzomib-based regimens in the United States by race. Clin Lymphoma Myeloma Leuk. 2023 Aug;23(8):616-625. doi: 10.1016/j.clml.2023.04.009.

Li S, Miller-Wilson LA, Guo H, Fisher DA. Adherence to colorectal cancer screening and healthcare resource utilization: a longitudinal analysis in Medicare beneficiaries aged 66-75 years. Curr Med Res Opin. 2022;38(12):2201-2208. doi: 10.1080/03007995.2022.2133493.

Li S, Miller-Wilson LA, Guo H, Hoover M, Fisher DA. Incident colorectal cancer screening and associated healthcare resource utilization and Medicare cost among Medicare beneficiaries aged 66-75 years in 2016-2018. BMC Health Serv Res. 2022 Oct 3;22(1):1228. doi: 10.1186/s12913-022-08617-8. 

Li Shuling, Ji Y, Peng Y, Kota V, Kim C. Patient characteristics, treatment patterns, and mortality in elderly patients newly diagnosed with acute myeloid leukemia meeting ineligibility criteria for high intensity chemotherapy. Leuk Lymphoma. 2022 Jan;63(1):131-141. doi: 10.1080/10428194.2021.1973669.

Engels EA, Haber G, Hart A, Lynch CF, Li J, Pawlish KS, Qiao B, Yu KJ, Pfeiffer RM. Predicted cure and survival among transplant recipients with a previous cancer diagnosis. J Clin Oncol. 2021 Dec 20;39(36):4039-4048. doi: 10.1200/JCO.21.01195.

Li S, Gong T, Kou C, Fu A, Bolanos R, Liu J. Clinical outcomes associated with chronic kidney disease in elderly Medicare patients with multiple myeloma. Clin Lymphoma Myeloma Leuk. 2021 Jun;21(6):401-412.e24. doi: 10.1016/j.clml.2021.01.015.

Li S, Liu J, Gong T, Guo H, Gawade P, Kelsh MA, Bradbury BD, Belani R, Lyman GH. Duration of short-acting granulocyte colony-stimulating factor for primary prophylaxis and risk of neutropenia-related hospitalization in older patients with cancer. J Geriatr Oncol. 2020 Nov;11(8):1309-1315. doi: 10.1016/j.jgo.2020.06.018.

Li S, Guo H, Peng Y, Gong T, Fu A, Bhowmik D, Hernandez RK, Carlson KB, Lowe KA, Rana J, Li S. Discharge status and post-discharge healthcare costs after skeletal-related event hospitalizations among Medicare patients with bone metastatic solid tumors or multiple myeloma. J Bone Oncol. 2020 Oct 21;26:100328. doi: 10.1016/j.jbo.2020.100328.

Li S, Peng Y, Liu J, Li S, Raskin L, Kelsh MA, Zaha R, Gawade PL, Henry D, Lyman GH. Variations in hospitalization and emergency department/observation stays using the oncology care model methodology in Medicare data. Curr Med Res Opin. 2020 Sep;36(9):1519-1527. doi: 10.1080/03007995.2020.1801403.

Li S, Liu J, Guo H, Gawade PL, Kim C, Bensink ME, Chandler D. Trends in the use of primary prophylactic colony-stimulating factors and neutropenia-related hospitalization in elderly patients receiving myelosuppressive chemotherapy in the USA: 1995-2015. Support Care Cancer. 2020 Jun;28(6):2637-2649. doi: 10.1007/s00520-019-05080-w.

Li S, Liu, J, Bowers C, Garawin TAFS, Kim C, Bensink ME, Chandler DB. Febrile neutropenia-related care and associated costs in elderly patients with breast cancer, lung cancer, or non-Hodgkin lymphoma. Support Care Cancer. 2020 Jan;28(1):113-122. doi: 10.1007/s00520-019-04795-0.

Li S, Natwick T, Liu J, Morrison VA, Vidito S, Werther W, Yusuf AA, Usmani SZ. Mortality by a proxy performance status as defined by a claims-based measure for disability status in older patients with newly diagnosed multiple myeloma in the United States. J Geriatr Oncol. 2019 May;10(3):490-496. doi: 10.1016/j.jgo.2019.01.007. 

Sosa R, Li S, Molony JT, Liu J, Stryker S, Collins AJ. Use of prophylactic growth factors and antimicrobials in elderly patients with cancer: A review of the Medicare database. Support Care Cancer. 2017 Oct;25(10):3123-3132. doi: 10.1007/s00520-017-3720-x.

Li S, Liu J, Virnig BA, Collins AJ. Association between adjuvant chemotherapy and risk of acute kidney injury in elderly women diagnosed with early stage breast cancer. Breast Cancer Res Treat. 2017 Feb;161(3):515-524. doi: 10.1007/s10549-016-4074-7.

Yusuf AA, Natwick T, Werther W, Felici D, Mahue M, Bridges KR, Peng Y. A retrospective analysis to examine factors associated with mortality in Medicare beneficiaries newly diagnosed with multiple myeloma. Curr Med Res Opin. 2016 Dec;32(12):1989-1996. doi: 10.1080/03007995.2016.1226166.

Arneson TJ, Li S, Gilbertson DT, Bridges KR, Acquavella JF, Collins AJ. Impact of Centers for Medicare & Medicaid Services national coverage determination on erythropoiesis-stimulating agent and transfusion use in chemotherapy-treated cancer patients. Pharmacoepidemiol Drug Saf. 2012 Aug;21(8):857-64. doi: 10.1002/pds.3257.

Li S, Peng Y, Weinhandl ED, Blaes AH, Cetin K, Chia VM, Stryker S, Pinzone JJ, Acquavella JF, Arneson TJ. Estimated number of prevalent cases of diagnosed bone metastases in the US adult population. Clin Epidemiol. 2012;4:87-93. doi: 10.2147/CLEP.S28339.

Posters & Presentations

Trends in Skeletal-Related Event Hospitalization and Use of Bone-Targeting Agents in Older Patients with Bone Metastases from Solid Tumors in the United States: 1994-2015. Shuling Li, Haifeng Guo, Suying Li, Rohini K. Hernandez, Jiannong Liu, Yi Peng, Alan Fu. Presented at the International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 2019.

Trends in Neutropenia-Related Hospitalization in Older Patients With Non-Hodgkin Lymphoma Receiving Myelosuppressive Chemotherapy in the United States: 1995–2015. Shuling Li, Jiannong Liu, Haifeng Guo, Prasad L. Gawade, Christopher Kim, Mark E. Bensink, and David Chandler. Presented at the American Society of Hematology Annual Meeting, 2018.

Variations in Hospitalization and Emergency Department/Observation Stays Using the Oncology Care Model Methodology in Medicare Data. Shuling Li, Yi Peng, Suying Li, Leon Raskin, Michael A. Kelsh, Rebecca Zaha, Prasad L. Gawade, David Henry. Presented at the American Society of Clinical Oncology Quality Care Symposium, 2018.

Hospitalization and Hospital Discharge Destinations After Chemotherapy: Using the Oncology Care Model Methodology in 2012–2015 Medicare Data. Yi Peng, Jiannong Liu, Shuling Li, Leon Raskin, Michael A. Kelsh, Rebecca Zaha, Rohini K. Hernandez, David Henry, Gary H. Lyman. Presented at the American Society of Clinical Oncology Quality Care Symposium, 2018.

Rituximab Use in Elderly Patients Newly Diagnosed with Primary Immune Thrombocytopenia. Shuling Li, Julia T. Molony, Anne Sexter, Karynsa Cetin, Ivy Altomare, Jeffery Wasser. Presented at the 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 2018.

Mortality by Frailty Status as Defined by a Claims-Based Disability Status in Elderly Patients with Newly Diagnosed Multiple Myeloma in the United States. Shuling Li, Tanya Natwick, Jiannong Liu, Vicki A. Morrison, Sarah Vidito, Winifred Werther, Khalid Mezzi, Akeem Yusuf, Jatin Shah, Saad Usmani. Presented at the International Myeloma Workshop, 2017. 

Transitions Across Different Lines of Therapy in Medicare-Enrolled Patient Populations with Multiple Myeloma. Akeem A. Yusuf, Tanya Natwick, Diana Felici, Winifred Werther. Presented at the American Society of Clinical Oncology Annual Meeting, 2016.

Treatment Regimens and Duration of Lines of Therapy in Medicare-Enrolled Patients with Multiple Myeloma. Akeem A. Yusuf, Tanya Natwick, Diana Felici, Winifred Werther. Presented at the American Society of Clinical Oncology Annual Meeting, 2016.

Treatment Sequencing Patterns in Medicare-Enrolled Patients with Multiple Myeloma. Shuling Li, Tanya Natwick, Akeem Yusuf, Sarah Vidito, Khalid Mezzi, Winifred Werther. Presented at the American Society of Hematology Annual Meeting, 2016.

Mortality among Elderly Patients Newly Diagnosed with Acute Lymphoblastic Leukemia (ALL), using 100% Medicare ALL Data. Shuling Li, Julia T. Molony, Victoria M. Chia, Aaron J. Katz. Presented at the American Society of Clinical Oncology Annual Meeting, 2016. 

Patient Characteristics and Treatment Patterns in Elderly Patients Newly Diagnosed with ALL using 100% Medicare ALL Data. Shuling Li, Julia T. Molony, Victoria M. Chia, Aaron J. Katz. Presented at the American Society of Hematology Annual Meeting, 2016. 

Association between Adjuvant Chemotherapy and Risk of Acute Kidney Injury in Elderly Women Diagnosed with Early Stage Breast Cancer. Shuling Li, Jiannong Liu, Beth A. Virnig, Allan J. Collins. Presented at the San Antonio Breast Cancer Symposium, 2014.

Association between Adjuvant Chemotherapy and Risk of Chronic Kidney Disease in Elderly Women Diagnosed with Early Stage Breast Cancer. Shuling Li, Jiannong Liu, Beth A. Virnig, Allan J. Collins. Presented at the San Antonio Breast Cancer Symposium, 2014.

Co-Morbidities in Elderly Breast Cancer and Lung Cancer Patients Who Receive Chemotherapy of NCCN Defined Intermediate Risk of Febrile Neutropenia. John H. Page, Shuling Li, Julia Molony, Romina Sosa, Richard Barron, Phuong Khanh Morrow, Scott Stryker, Jiannong Liu, Allan J. Collins, John Acquavella. Oral presentation at the Multinational Association of Supportive Care in Cancer, 2014.

Co-Morbidities in Elderly Breast Cancer Patients Treated with Chemotherapy. Romina Sosa, Julia Molony, Shuling Li, Richard Barron, Phuong Khanh Morrow, Scott Stryker, Jiannong Liu, Allan J. Collins, John Acquavella. Oral Presentation at the Multinational Association of Supportive Care in Cancer, 2014.

Mortality among Women Diagnosed with Stage II or III Breast Cancer Based on SEER-Medicare Data. Rohini K. Hernandez, Alexander Liede, Shuling Li, Jiannong Liu, Yan Hu, Scott Stryker, Anne H. Blaes, Allan J. Collins. Oral presentation at the American Society of Clinical Oncology Breast Cancer Symposium, 2014.

Prevalence of Nonmetastatic Prostate Cancer Patients on Continuous Androgen Deprivation Therapy in the United States. Karynsa Cetin, Shuling Li, Anne H. Blaes, Scott Stryker, Alexander Liede, Thomas J. Arneson. Presented at the American Society of Clinical Oncology Annual Meeting, 2012.

Patterns of Granulocyte Colony Stimulating Factor (G-CSF) Use in Elderly Breast Cancer Patients Receiving Myelosuppressive Chemotherapy. Anne Blaes, John Page, Craig Solid, Victoria Chia, Mi Rim Choi, Rich Barron, Tom Arneson. Presented at the San Antonio Breast Cancer Symposium, 2012.

Prevalence of Recognized Bone Metastases in the US Adult Population. Shuling Li, Yi Peng, Eric D. Weinhandl, Anne H. Blaes AH, Karynsa Cetin, Victoria M. Chia, Scott Stryker, Joseph J. Pinzone, John F. Acquavella, Thomas J. Arneson. Presented at the American Society of Clinical Oncology Annual Meeting, 2011.

Impact of Medicare’s July 2007 Erythropoiesis Stimulating Agent (ESA) National Coverage Determination (NCD) on Transfusion Use in Chemotherapy-Treated Cancer Patients. Thomas J. Arneson, Shuling Li, David T. Gilbertson, Stephan C. Dunning, Kenneth R. Bridges, John F. Acquavella. Presented at the American Society of Clinical Oncology Annual Meeting, 2010.

Publications

View papers published under the Scientific Registry of Transplant Recipients (SRTR).

Hart A, Schladt DP, Matas AJ, Itzler R, Israni AK, Kasiske BL. Incidence, risk factors, and long-term outcomes associated with antibody-mediated rejection—the long-term deterioration of kidney allograft function (DeKAF) prospective cohort study. Clin Transplant. 2021 Jul;35(7):e14337. doi: 10.1111/ctr.14337. 

Hart A, Singh D, Brown SJ, Wang JH, Kasiske BL. Incidence, risk factors, treatment and consequences of antibody-mediated kidney transplant rejection: A systematic review. Clin Transplant. 2021 Jul;35(7):e14320. doi: 10.1111/ctr.14320.

Hart A, Zaun D, Itzler R, Schladt D, Israni A, Kasiske B. Cost, healthcare utilization, and outcomes of antibody-mediated rejection in kidney transplant recipients in the US. J Med Econ. 2021 Jan-Dec;24(1):1011-1017. doi: 10.1080/13696998.2021.1964267.

Dellay B, Sexter A, Wang JH, Hess GP, Kim WR, Israni AK. Impact of sofosbuvir-based therapy on liver transplant candidates with hepatitis C virus infection. Pharmacotherapy. 2019 Apr;39(4):424-432. doi: 10.1002/phar.2237. 

Wang JH, Skeans MA, Israni AK. Current status of kidney transplant outcomes: Dying to survive. Adv Chronic Kidney Dis. 2016 Sep;23(5):281-286. doi: 10.1053/j.ackd.2016.07.001.

Israni AK, Snyder JJ, Skeans MA, Kasiske BL; PORT Investigators. Clinical diagnosis of metabolic syndrome: Predicting new onset diabetes, coronary heart disease, and allograft failure late after kidney transplant. Transpl Int. 2012 Jul;25(7):748-57. doi: 10.1111/j.1432-2277.2012.01488.x.

Kasiske BL, Kukla A, Thomas D, Wood Ives J, Snyder JJ, Qui Y, Peng Y, Dharnidharka VR, Israni AK. Lymphoproliferative disorders after adult kidney transplant: Epidemiology and comparison of registry report with claims-based diagnoses. Am J Kidney Dis. 2011 Dec;58(6):971-80. doi: 10.1053/j.ajkd.2011.07.015.

Ibrahim HN, Ishani A, Snyder JJ, Skeans M, Li Q. Blood transfusions in kidney transplant candidates are common and associated with adverse outcomes. Clin Transplant. 2011 Jul-Aug;25(4):653-9. doi: 10.1111/j.1399-0012.2011.01397.x.

Pilmore HL, Skeans MA, Snyder JJ, Israni AK, Kasiske BL, for the PORT Investigators. Cardiovascular disease medications after renal transplantation: Results from the Patient Outcomes in Renal Transplantation Study. Transplantation. 2011 Mar 15;91(5):542-51. doi: 10.1097/TP.0b013e31820437bd.

Kasiske BL, Israni AK, Snyder JJ, Skeans MA; Patient Outcomes in Renal Transplantation (PORT) Investigators. The relationship between kidney function and long-term graft survival after kidney transplant. Am J Kidney Dis. 2011;57:466-475. doi: 10.1053/j.ajkd.2010.10.054.

Kasiske BL, Israni AK, Snyder JJ, Skeans MA, Peng Y, Weinhandl ED. A simple tool to predict outcomes after kidney transplant. Am J Kidney Dis. 2010 Nov;56(5):947-60. doi: 10.1053/j.ajkd.2010.06.020.

Israni AK, Snyder JJ, Skeans MA, Peng Y, Maclean JR, Weinhandl ED, Kasiske, BL, for the PORT Investigators. Predicting coronary heart disease after kidney transplantation: Patient Outcomes in Renal Transplantation (PORT) Study. Am J Transplant. 2010 Feb;10(2):338-53. doi: 10.1111/j.1600-6143.2009.02949.x.

Snyder JJ, Israni AK, Peng Y, Zhang L, Simon TA, Kasiske BL. Rates of first infection following kidney transplant in the United States. Kidney Int. 2009 Feb;75(3):317-26. doi: 10.1038/ki.2008.580.

Israni AK, Snyder JJ, Skeans MA, Tuomari AV, Maclean JR, Kasiske BL. Who is caring for kidney transplant patients? Variation by region, transplant center, and patient characteristics. Am J Nephrol. 2009;30(5):430-9. doi: 10.1159/000239220.

Posters & Presentations

Characterization and Waiting List Outcomes of Patients with CF Listed for Lung Transplantation. Lasair O’Callaghan, Julia Molony, Yi Peng, Ellison Suthoff, Jon Snyder, David Waltz. Presented at the North American Cystic Fibrosis Conference, 2016.

Incidence of Kidney Transplant in Daily Home Hemodialysis, Peritoneal Dialysis, and In-Center Hemodialysis Patients. Eric Weinhandl, Allan Collins. Presented at the National Kidney Foundation Spring Clinical Meeting, 2015.

Publications

Kempainen S, Cutts DB, Robinson-O'Brien R, De Kesel Lofthus A, Gilbertson DT, Mino R. A collaborative pilot to support patients with diabetes through tailored food box home delivery. Health Promot Pract. 2023 Sep;24(5):963-968. doi: 10.1177/15248399221100792. 

Levintow SN, Nielson CM, Hernandez RK, Breskin A, Pritchard D, Lash TL, Rothman KJ, Gilbertson D, Muntner P, Critchlow C, Brookhart MA, Bradbury BD. Pragmatic considerations for negative control outcome studies to guide non-randomized comparative analyses: A narrative review. Pharmacoepidemiol Drug Saf. 2023 Jun;32(6):599-606. doi: 10.1002/pds.5623. 

Wetmore JB, Peng Y, Yan H, Li S, Irfan M, Shim A, Roetker NS, Abler V, Rashid N, Gilbertson DT. Association of dementia-related psychosis with long-term care use and death. Neurology. 2021 Mar 23;96(12):e1620-e1631. doi: 10.1212/WNL.0000000000011632. 

Wetmore JB, Li S, Yan H, Irfan M, Rashid N, Peng Y, Gilbertson DT, Shim A. Increases in institutionalization, healthcare resource utilization, and mortality risk associated with Parkinson disease psychosis: Retrospective cohort study. Parkinsonism Relat Disord. 2019 Nov;68:95-101. doi: 10.1016/j.parkreldis.2019.10.018.

Li S, Molony JT, Cetin K, Wasser JS, Altomare I. Rate of bleeding-rated episodes in elderly patients with primary immune thrombocytopenia: A retrospective cohort study. Curr Med Res Opin. 2018 Feb;34(2):209-216. doi: 10.1080/03007995.2017.1360852.

Gilbertson DT, Bradbury BD, Wetmore JB, Weinhandl ED, Monda KL, Liu J, Brookhart MA, Gustafson SK, Roberts T, Collins AJ, Rothman KJ. Controlling confounding of treatment effects in administrative data in the presence of time-varying baseline confounders. Pharmacoepidemiol Drug Saf. 2016 Mar;25(3):269-277. doi: 10.1002/pds.3922.

Posters & Presentations

Healthcare Resource Utilization and Costs of Parkinson’s Disease Dementia With Psychosis in the US Medicare Population. James B. Wetmore, Heng Yan, Muna Irfan, Yi Peng, David T. Gilbertson, Suying Li, Nazia Rashid, Andrew Shim. Presented at the International Congress of Parkinson’s Disease and Movement Disorder Society®, 2019.

Rituximab Use in Elderly Patients Newly Diagnosed with Primary Immune Thrombocytopenia. Shuling Li, Julia T. Molony, Anne Sexter, Karynsa Cetin, Ivy Altomare, Jeffrey Wasser. Presented at the Thrombosis & Hemostasis Societies of North America Biennial Summit, 2018.

Splenectomy in Elderly Patients Newly Diagnosed with Primary Immune Thrombocytopenia. Shuling Li, Anne Sexter, Julia T. Molony, Karynsa Cetin, Jeffrey Wasser, Ivy Altomare. Presented at the Thrombosis & Hemostasis Societies of North America Biennial Summit, 2018.

Rate of Bleeding-Rated Episodes (BREs) in Elderly Patients with Primary Immune Thrombocytopenia (ITP): A Population-Based Retrospective Cohort Study Using Medicare 20% Sample Data. Shuling Li, Julia T. Molony, Karynsa Cetin, Jeffrey S. Wasser, Ivy Altomare. Oral presentation at the American Society of Hematology Annual Meeting, 2015.

Elevated Risk of End-Stage Renal Disease, Cardiovascular Events, and Infection Associated With Diabetic Kidney Disease. James B. Wetmore, Suying Li, Thanh G.N. Ton, Cheryl Neslusan, Michael K. Hansen, Ralph Riley, David T. Gilbertson. Presented at the American Diabetes Association Scientific Sessions, 2017.

New Policies, New Sources of Error: Impact of Recent Medicare Policies on Database Research. David T. Gilbertson, Jiannong Liu, Anne C. Beaubrun, Glenn M. Chertow, Kenneth J. Rothman, Wolfgang C. Winkelmayer, Keri L. Monda, Akhtar Ashfaq, M. Alan Brookhart, Allan J. Collins, Brian D. Bradbury. Presented at the International Society Pharmacoepidemiology Annual Conference, 2016.

Potential Effects of Medicare Payment Policy Changes on Hospitalization-Based Outcomes Research. Anne C. Beaubrun, David Gilbertson, Glenn Chertow, Kenneth Rothman, Wolfgang Winkelmayer, Keri Monda, Jiannong Liu, Akhtar Ashfaq, M. Alan Brookhart, Allan Collins, Brian Bradbury. Presented at the International Society Pharmacoepidemiology Annual Conference, 2016.

Association of Potassium with Mortality: Data from a Metropolitan Safety-Net Hospital. Charles A. Herzog, James B. Wetmore, Wendy L. St. Peter, David T. Gilbertson. Presented at the American Heart Association Scientific Sessions, 2016.